Abstract
Background
Numerous studies have reported myocarditis resulting from messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccination. However, to date, there have been no reports highlighting the safety of mRNA COVID-19 vaccines in children and adults with a prior history of myocarditis, which was the intent of this study.
Methods and Results
Children and adults cared for at the Cleveland Clinic were identified through the electronic health records, who had a history of myocarditis before the COVID-19 pandemic and had subsequently received at least 2 doses of the mRNA COVID-19 vaccines (n = 34). Only 1 patient in this series had recurrence of myocarditis confirmed by cardiac magnetic resonance imaging after receiving the second dose. He was a White man who had his first episode of myocarditis at age 20 and was 27 years of age at the time of recurrence. He was hospitalized for 2 days with no need for cardiac support or reported arrhythmias and was stable at outpatient follow-up.
Conclusions
In patients with an old history of non–COVID-19 myocarditis, the risk of recurrent myocarditis after receipt of mRNA COVID-19 vaccination is low, and when it occurs it seems to be self-limiting. Our study will be valuable to clinicians while discussing the risk–benefit ratio of vaccinations in patients with a prior history of myocarditis.
【저자키워드】 vaccine safety, Myocarditis history, mRNA COVID-19 vaccine, 【초록키워드】 COVID-19, coronavirus disease, vaccination, Hospitalized, magnetic resonance imaging, children, COVID-19 pandemic, risk, arrhythmia, COVID-19 vaccination, myocarditis, mRNA, Patient, age, Follow-up, dose, Electronic health records, Support, Messenger RNA, clinician, second dose, clinic, white, Result, resulting, reported, receiving, occur, highlighting, Numerous, Cleveland, 【제목키워드】 COVID-19, mRNA, history,